AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2010
Jun 30, 2010
31542_dirs_2010-06-30_7b328b86-44cc-47a4-9071-6d50262c4e41.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Catalyst Pharmaceutical Partners, Inc. (CPRX)
CIK: 0001369568
Period of Report: 2010-06-17
Reporting Person: O'Keeffe Charles B (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-06-17 | Common Stock, par value $0.001 per share | P | 2000 | $1.0495 | Acquired | 80876 | Direct |
More from CATALYST PHARMACEUTICALS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jul 8
Proxy Solicitation & Information Statement
2026
Jun 30
Regulatory Filings
2026
Jun 30
Regulatory Filings
2026
Jun 23
M&A Activity
2026
Jun 8
Report Publication Announcement
2026
May 11
M&A Activity
2026
May 7
Major Shareholding Notification
2026
Mar 26
Call Transcript
2026
Mar 10
Call Transcript
2026
Feb 26